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Aim: To delineate the sleep profile of Borderline Personality Disorder (BPD). 
 
Method: A meta-analysis to synthesise findings on the objective and subjective sleep 
characteristics of BPD. 
 
Results: We identified 32 studies published between 1980 and December 2015. Meta-
analysis indicated significant differences between BPD and healthy control groups across 
objective sleep continuity (sleep onset latency, total sleep time, sleep efficiency) and 
architecture (rapid eye movement latency/density, slow wave sleep) measures, and self-
reported sleep problems (nightmares, sleep quality). Findings were independent of depression 
(in clinical and community populations), and concomitant psychotropic medication use. 
There were few significant differences between BPD and clinical (majority depressed) 
control groups.  
 
Conclusion: BPD is associated with comparable sleep disturbances to those observed in 
depression. These disturbances are not solely attributable to comorbid depression. Given 
growing evidence that sleep disturbance may exacerbate emotional dysregulation and suicide 
risk, treatments for BPD should explicitly address sleep problems. Future studies should 
utilise prospective designs to ascertain whether (and in which circumstances) sleep problems 
predate or follow the onset of the disorder.  
 
Keywords: BPD; sleep; polysomnography; meta-analysis; systematic review
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1. Introduction 
 
Borderline Personality Disorder (BPD) is a chronic mental disorder, which often first 
manifests in adolescence (Kaess, Brunner, & Chanen, 2014; Winsper et al., 2016; Winsper et 
al., 2015). It comprises a wide range of debilitating symptoms including mood instability, 
inappropriate anger, impulsive behaviour, disturbances in self-identity, unstable relationships, 
abandonment fears, and self-harm (Lieb, Zanarini, Schmahl, Linehan, & Bohus, 2004).  
Studies indicate that individuals with BPD may experience sleep disturbances in 
comparison to healthy (Bastien, Guimond, St-Jean, & Lemelin, 2008; Benson, King, Gordon, 
Silva, & Zarcone, 1990) and depressed (De la Fuente et al., 2004) controls. Nevertheless, the 
sleep profile of BPD has received relatively limited clinical and research attention (Winsper 
& Tang, 2014). A greater understanding of sleep disturbance in BPD may help enrich 
treatment protocols, which currently place rather limited emphasis on sleep difficulties 
(National Institute for Clinical Excellence, 2009; Selby, 2013). Furthermore, elucidating the 
extent to which BPD is independently associated with sleep problems may provide a more 
coherent picture of the phenomenological and biological nature of this complex disorder 
(Goodman, New, Triebwasser, Collins, & Siever, 2010; Simor & Horváth, 2013).  
 Narrative reviews have considered aspects of sleep in BPD (please see Table 1 for a 
list of acronyms and associated full names used throughout the review). Hafizi (2013) 
concluded that BPD is associated with several sleep abnormalities, including disturbances in 
continuity, reduced Rapid Eye Movement (REM) latency (though findings were 
inconsistent), and nightmares. Similarly, Simor and Horváth (2013) reported that sleep 
fragmentation, alterations in Slow Wave Sleep (SWS) – though again results were mixed, 
shortened REM latency, and dysphoric dreaming are prevalent in BPD. In a narrative 
synthesis of 12 polysomnography (PSG) studies, Oltmanns and Oltmanns (2015a) reported 
differences in sleep between BPD patients and healthy controls including less total sleep time 
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(TST), decreased sleep efficiency (SE), longer sleep onset latency (SOL) and more frequent 
arousals. The authors concluded that BPD may be independently associated with sleep 
disturbances.  
[Insert Table 1 about here] 
 
While these narrative reviews are informative, inconsistent results across studies make robust 
conclusions regarding sleep in BPD difficult to formulate (Hafizi, 2013). Inconsistencies are 
likely to be attributable to small samples sizes resulting in underpowered analyses (Harty, 
Forkner, Thompson, Stuewig, & Tangney, 2010), and variations in study methodology (e.g., 
methods of assessment, differing sample characteristics) which may moderate (or mask) 
pertinent group differences. Finally, the lack of systematic search procedures may have led to 
the omission of important studies inflating risk of biased conclusions (Cipriani & Geddes, 
2003). 
To address these issues, we conducted a systematic review and meta-analysis of sleep 
studies in BPD populations. Our main aim was to quantitatively examine the sleep profile 
(i.e., continuity, architecture, and nightmares) of individuals with BPD, and determine 
whether it can be distinguished from that of individuals with other (and no) mental disorders. 
Specifically, we addressed the following research questions: 
 
 Do individuals with BPD significantly differ from healthy and clinical controls on 
objective measures of sleep continuity (i.e., SOL, TST, WASO, NWAKE, SE) and 
sleep architecture (i.e., stage 1 sleep, stage 2 sleep, SWS, and REM)? 
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 Are effect sizes for group differences in sleep moderated by study features (i.e., co-
morbid depression status, sample frame, sleep assessment, gender, age, and study 
quality)? 
 
 Do individuals with BPD significantly differ from controls on subjective measures of 
sleep (e.g., nightmares, sleep quality)? 
 
 Is there a subjective-objective discrepancy in the sleep measures of individuals with 
BPD? 
 
2. Method 
2.1. Search and selection of studies 
Prior to formulating the protocol, C.W conducted a pilot search to ensure that a systematic 
review pertaining to the research questions had not been previously published or registered. 
The Cochrane Database of Systematic Reviews (CDSR), the Centre for Reviews and 
Dissemination (CRD), and www.pubmed.gov (Sayers, 2008) were accessed for the scoping 
search. We used MOOSE: Meta-analysis of Observational Studies in Epidemiology (Stroup 
et al., 2000) and PRISMA: Preferred Reporting Items for Systematic Review and Meta-
analysis (Moher et al., 2015) guidelines as a framework. Methods of analysis and inclusion 
criteria were specified in advance and documented in the protocol (Liberati et al., 2009).  
We searched Embase, PsycINFO, and PubMed from 1980 (when BPD was first introduced as 
a disorder in the DSM-III) to December 2015. Search terms were agreed by the authors 
following consultation of relevant published reviews and the pilot search. We used the 
grouped terms (borderline* OR BPD OR “emotionally unstable personality disorder”) and 
(sleep* OR nightmare* OR dream* OR REM OR insomnia OR hypersomnia OR 
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wakefulness OR polysomnograph* OR EEG OR circadian*). Reference lists of retrieved 
articles and review papers were inspected to enhance search sensitivity. T.L & C.W 
independently searched 100% of the abstracts for full text retrieval. C.W and M.G 
independently searched 100% of the full text articles for inclusion in the review.  
2.2. Inclusion criteria 
First, we defined criteria for studies to be included in the overall review, which were applied 
to the systematic narrative synthesis and meta-analytic sections. Second, we applied further 
inclusion criteria for the meta-analysis. 
To be included in the overall review studies had to: 
1) Be published in English; 
2) Be primary research in a peer reviewed journal; 
3) Report group comparisons between participants with BPD and healthy or clinical 
controls on any sleep characteristic, or report associations between BPD symptoms 
and any sleep characteristic; 
4) Be based on adolescent or adult samples (defined as 11 years of age or older); 
5) Include a clinical, high-risk (e.g., prison) or community population; 
6) Report either an objective (e.g., EEG) or subjective (e.g., self-report) assessment of 
sleep. 
 
To be included in the meta-analysis, studies had to also: 
7) Use a validated assessment of BPD (i.e., questionnaire, structured interview, clinical 
diagnosis);  
8) Report data (e.g., group means, standard deviations) to allow for the calculation of an 
effect size for group differences; 
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2.3. Exclusion criteria 
1) Case reports; 
2) Studies of sleep problems in personality disorders in general rather than BPD 
specifically 
2.4. Data extraction 
A data extraction form was developed prior to manuscript review. It included: author details, 
country of study, sample characteristics (i.e., age, sex, and sample frame), study design, BPD 
and sleep assessments, and effect sizes and associated variance for the sleep variables. The 
data extraction sheet also included a quality assessment (QA) tool based on the Newcastle-
Ottawa Scale (NOS), which can be adapted for non-randomised cross-sectional and case-
control studies (Wells et al., 2000). The NOS is based on a star system in which each case 
control study is assessed on three broad domains: selection (maximum of 4 stars); 
comparability (maximum of 2 stars) and exposure (maximum of 3 stars). We used the 
adapted scale by Herzog et al. (2013) for cross sectional studies, covering the similar domains 
of selection (maximum of 5 stars); comparability (maximum of 2 stars); and outcome 
(maximum of 3 stars). The content validity and inter-rater reliability of the NOS have been 
established (Wells et al., 2000). As we expected to identify a limited number of relevant 
articles, we did not exclude studies according to a study quality threshold. Instead, we used 
moderator analysis to determine whether study quality impacted on pooled results.   
2.5. Meta-analysis 
Meta-analysis for each sleep variable was conducted by computing weighted summary 
measures using Stata version 13 (Stata Corp, College Station, TX, USA). Due to 
methodological and sample variations, we expected studies to be heterogeneous, and that 
sleep disturbances would vary more than expected by chance alone. Thus, we selected the 
random-effects model (DerSimonian & Laird, 1986) with the inverse-variance method to 
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calculate summary estimates. We compared BPD groups to healthy and clinical controls. As 
most (but not all) clinical control groups were depressed patients, we repeated the analysis 
with depressed only controls as a sensitivity test. In view of the potential effects of 
psychotropic medications on sleep (Whitney et al., 1998), we conducted a second sensitivity 
test excluding studies in which patients were taking psychotropic or sleep medication at the 
time of testing.   
The standardised mean difference (SMD) was the principal summary measure. The 
SMD is particularly appropriate for the synthesis of studies assessing the same concept (e.g., 
subjective sleep quality) with a variety of continuous scales (e.g., Pittsburgh Sleep Quality 
Index, Schlaffragebogen B scale). Heterogeneity was quantitatively assessed using the I-
squared statistic to ascertain whether pooled studies represented a homogeneous distribution 
of effect sizes. Evidence regarding publication bias was assessed using funnel plots. Funnel 
plots are scatter graphs, which plot the effect sizes of individual studies (horizontal axis) 
against a measure of study size (vertical axis). Publication bias (reported in Table 3) is 
indicated by asymmetrical funnel plots, e.g., if smaller studies showing no statistical effect 
remain unpublished there will be a gap in the right (or left for negative effects) bottom side of 
the graph (Sterne & Harbord, 2004).  
2.6. Subgroup analysis and meta-regressions 
We addressed research question two (i.e., study factors associated with heterogeneity) using 
subgroup analyses and meta-regression. We selected factors previously suggested to 
influence sleep including: comorbid depression status (Holsboer-trachsler & Seffritz, 2000), 
age (Ohayon, Carskadon, Guilleminault, & Vitiello, 2004), gender (Mongrain, Carrier, & 
Dumont, 2005), sample type (Topf & Thompson, 2001), and sleep assessment tool (Hornung 
et al., 2008). We performed subgroup analysis by categorical factors including: comorbid 
depression status (0=no history of, or current, depression; 1=no current depression; 2 = 
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comorbid depression); sample type (0=inpatients; 1=outpatients; 2=prison population); sleep 
assessment (0=lab polysomnography; 1=less optimal/indirect sleep assessment method); and 
gender (0=mixed sample; 1 = all females; 2 = all males). We then performed meta-regression 
to estimate the extent to which each of these variables (and age and QA score entered as 
continuous variables) explained the observed heterogeneity in pooled SMD estimates 
(Higgins & Thompson, 2002).  
3. Results 
3.1. Search results 
Of the 972 abstracts scanned, we identified 49 articles for full text retrieval. Interrater 
agreement was very good (Kappa=0.87). C.W. and T.L discussed any discrepancies, which 
were largely due to uncertainty regarding whether the study reported relevant sleep variables 
(e.g., in some cases it wasn’t clear whether EEG measures referred to sleep specifically). If 
there was any doubt over whether an abstract should be included for full text retrieval, we 
made the decision to include it. Of the 49 full text articles inspected, 32 were identified for 
inclusion in the review. Interrater agreement was excellent (Kappa=0.90). Of these 32 
studies, 20 were also eligible for inclusion in the meta-analysis, 14 (two studies were 
included in the MA and narrative synthesis) were synthesised narratively (see Figure 1). 
Reasons for non-inclusion in the meta-analysis included: the reporting of overlapping data 
(De la Fuente et al., 2004); insufficient data to convert into a common effect size (Bromundt 
et al., 2013); and the uniqueness of the sleep factor (Dagan, Stein, Steinbock, Yovel, & 
Hallis, 1998), i.e., it wasn’t assessed in a minimum of two studies. 
 
[Insert Figure 1 about here] 
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See Table 2 for details and main results of studies. Two studies were prospective (Lereya, 
Winsper, Tang, & Wolke, 2016; Selby, Ribeiro, & Joiner Jr, 2013), the remainder were cross-
sectional. Twenty-four studies (inpatients, n=11; outpatients, n=13) used clinical samples, 
five community samples (1 nationally representative sample, 1 large community cohort of 
young adolescents, 1 student sample, 1 older population, and 1 sample recruited for self-
reported difficulties with dysregulated behaviours), and three prison populations. Eleven 
studies reported an objective sleep measure, fifteen a subjective sleep measure, and six both 
objective and subjective measures. Nearly all studies examining objective sleep measures 
used polysomnography in laboratory conditions. One study utilised a portable 
electroencephalogram sleep recording device (Hornung et al., 2008), while two utilised wrist 
actigraphy (Bromundt et al., 2013; Huỳnh, Guilé, Breton, & Godbout, 2015). 
Most studies with clinical control groups included depressed patients with the 
exception of one group of prisoners with Antisocial Personality Disorder (Lindberg et al., 
2003), one group of patients with insomnia (Bastien et al., 2008), and one group of adolescent 
outpatients with bipolar disorder (Huỳnh et al., 2015). Most studies reported a psychotropic 
medication wash-out period (usually of 2 weeks) prior to sleep assessment; five did not report 
a wash-out period (Huỳnh et al., 2015; Plante, Frankenburg, Fitzmaurice, & Zanarini, 2013b; 
Selby et al., 2013; Simor, Csóka, & Bódizs, 2010; Taherifard, Abolghasemi, & Hajloo, 
2015). Adult samples were used in most studies; only three had adolescent samples (Dagan et 
al., 1998; Huỳnh et al., 2015; Lereya et al., 2016).  
 
[Insert Table 2 about here] 
3.2. Quality assessment 
The findings from the quality assessment are reported in Supplementary Tables 1 & 2. 
Scores ranged from 2 to 7 points (out of a possible 9/10).  Nearly all studies performed poorly 
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on representativeness of sample and response rate (which was often not reported in studies, 
precluding assessment). Most studies performed well on comparability of cases and controls 
by either matching control groups carefully, or controlling for pertinent confounders.  
3.3. Meta-analysis results 
3.3.1 Studies with objective sleep assessments  
Detailed results (including the Standardised Mean Difference: SMD, confidence intervals, 
heterogeneity statistics, sensitivity analysis, p-values, and publication bias) are reported in 
Tables 3 and 4. Please see Figures 2, 3 & 4 for summary forest plots. Below we outline the 
direction of results.  
BPD versus healthy control groups 
Individuals with BPD had significantly longer SOL and WASO, and greater NWAKE and 
REM density than healthy control groups. They also had significantly shorter TST and REM 
latency, and lower SE than healthy control groups. Groups did not differ in % of REM sleep, 
and stage-1 or stage-2 sleep (Figure 2).   
 
[Insert Table 3 here] 
[Insert Figure 2 here] 
 
There was significant heterogeneity across studies for SOL, TST, NWAKE, SE, REM 
latency, REM density and stage-2 sleep. In sub-group analyses (Table 4), many significant 
differences between BPD and healthy groups remained robust across depression status (i.e., 
no history, no current, comorbid) groups (see Figure 3); differences were mainly robust in 
inpatient groups (TST, SOL, SE, and REM latency); those assessed with polysomnography 
(TST, SOL, SE, and REM latency); and mixed sex samples (TST, SOL, SE, REM latency, 
REM density).  
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[Insert Table 4 here] 
(Insert Figure 3 here] 
 
There were few significant predictors of heterogeneity in the meta-regression analyses. Sleep 
assessment tool (i.e., the use of polysomnography significantly predicted a negative SMD of 
TST) and sample type (i.e., the SMD of SOL was significantly greater in the mixed sex 
sample than the female only sample, and the SMD of NWAKE was significantly greater in 
the male sex group than the mixed sex samples) significantly accounted for heterogeneity for 
some of the sleep indices (see Supplementary Table 3).  
BPD versus clinical controls 
Individuals with BPD did not significantly differ from all clinical control groups or depressed 
only groups on any of the sleep indices (see Table 3 and Figure 4).   
 
[Insert Figure 4 here] 
 
There was significant heterogeneity across studies for SE, SWS, and REM latency. Sub-
group analyses for these indices indicated some subtle differences according to study factors 
(full results on request from authors). For SE, BPD individuals who had never been 
depressed, and outpatients, had significantly higher SE than CCs. In contrast, BPD 
individuals who were prisoners had significantly lower SE than CCs. For SWS, BPD 
individuals without co-morbid depression and those who were prisoners had significantly less 
slow wave sleep than CCs. For REM latency, BPD patients who had never been depressed 
had longer REM latencies than CCs, while REM latency was significantly shorter in BPD 
individuals than controls in the prison population.  
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There were few significant predictors of heterogeneity in the meta-regression analyses. 
Sample type (i.e., the SMD of SE was significantly lower in the prison population than the 
inpatient groups) and study quality (i.e., the SMD of SE was higher in the studies of higher 
quality) significantly moderated effect size for some of the sleep indices (full results on 
request from authors).  
3.3.2. Studies with self-reported sleep assessments  
Studies considering self-reported sleep characteristics examined nightmares, sleep quality, 
SOL, TST, and SE. See Table 5 and Figure 5 for a summary of the meta-analysis findings. 
 
[Insert Figure 5 here] 
 
[Insert Table 4 here] 
 
Individuals with BPD reported significantly more nightmares, significantly poorer sleep 
quality, and significantly longer SOL than controls. Groups did not differ in self-reported 
TST or SE. There was significant heterogeneity across studies for nightmares, sleep quality, 
TST, and SE. We did not conduct meta-regressions due to the small number of studies. Sub-
group analysis indicated that BPD patients without co-morbid depression, and both inpatients 
and outpatients experienced significantly more nightmares than controls. Subjective sleep 
quality was worse in BPD patients without co-morbid depression, and in both inpatients and 
outpatients (full results on request from authors).  
3.4. Summary of results from the narrative synthesis 
We narratively summarised results from studies that could not be quantitatively combined. 
Below we outline the pattern of findings. Please refer to Table 2 for more details on 
individual study results.  
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3.4.1. Circadian rhythm abnormalities 
The circadian rhythm (or “body clock”) is an endogenously-driven roughly 24-hour cycle, 
which tells our bodies when to sleep, and regulates other physiological process. Three studies 
indicated irregularities in circadian rhythms in BPD. Individuals with BPD appear more 
susceptible to delayed sleep phase syndrome: DSPS (Dagan et al., 1998); experience greater 
variability in Relative Amplitude, i.e., the distribution of activity between day and night 
(Bromundt et al., 2013); and experience wider sleep variability between weekdays and 
weekends (Huỳnh et al., 2015).  
3.4.2. Nightmares  
Findings from the narrative synthesis were consistent with the meta-analysis, demonstrating 
significant associations between nightmares and BPD in clinical (Lloyd, Overall, Kimsey, & 
Click Jr, 1983) and community (Claridge, Davis, Bellhouse, & Kaptein, 1998; Lereya et al., 
2016) populations. Furthermore, although preliminary, there was evidence for a prospective 
association between nightmares and BPD symptoms over both short (Selby et al., 2013) and 
long (Lereya et al., 2016) periods of time. These studies suggest that nightmares may 
exacerbate daytime dysregulation contributing to worsening symptoms (Selby et al., 2013), 
and possibly the development of BPD (Lereya et al., 2016).    
3.4.3. Self-reported sleep-quality and maladaptive sleep cognitions 
Also consistent with the meta-analysis, there was evidence for a significant association 
between subjective poor sleep quality/insomnia symptoms and BPD in clinical (Bromundt et 
al., 2013; Sansone, Edwards, & Forbis, 2010), prison (Harty et al., 2010), and community 
(Oltmanns, Weinstein, & Oltmanns, 2014; Selby, 2013) populations. Plante, Frankenburg, 
Fitzmaurice, and Zanarini (2013a) found that maladaptive cognitions about sleep (i.e., 
perceived consequences of insomnia; worry/helplessness about insomnia; expectations about 
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sleep; and attitudes about sleep medication) distinguished those who continued to meet BPD 
criteria from those who didn’t. 
4. Discussion 
We examined the specific sleep profile of individuals with BPD by pooling the results of 
studies comparing BPD patients to healthy and clinical controls. Further, we conducted sub-
group analyses to determine the extent to which group differences were moderated by 
pertinent study factors. Studies not suitable for meta-analysis were synthesised narratively. 
4.1. Summary of findings 
4.1.1. Do individuals with BPD significantly differ from healthy and clinical controls on 
objective sleep measures, and are pooled results moderated by study factors? 
The meta-analysis indicated robust differences between BPD and HC groups across sleep 
continuity measures (i.e., SOL, TST, SE, WASO, and NWAKE). Our results extend previous 
reviews (Hafizi, 2013; Oltmanns & Oltmanns, 2015a) by quantitatively demonstrating 
significant differences between BPD and HC groups across all sleep continuity measures. 
Sub-group analyses indicated some variations according to study-based characteristics.  
Differences were robust in sub-groups of BPD patients without any history of (SOL, 
TST, and SE) or concurrent (NWAKE) depression. This lends some support to the previous 
suggestion that sleep continuity problems are independently associated with BPD, rather than 
being a consequence of comorbid depression (Oltmanns & Oltmanns, 2015a). Subgroup 
analysis also demonstrated that differences between BPD and HC groups were significant in 
studies utilising polysomnography (rather than wrist actigraphy or other non-lab-based 
devices), and in inpatient populations. The more robust findings in polysomnography studies 
are perhaps unsurprising as this technique is often considered as the gold standard of sleep 
assessment methods (Hornung et al., 2008). The more robust findings in inpatient groups 
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could be partly attributable to the severity of BPD symptoms, which may be associated with 
more pronounced objective sleep problems (Bastien et al., 2008).  
Results were less consistent for sleep architecture. BPD groups did not significantly 
differ from HCs in stage 1 or 2 sleep, or percentage of REM sleep. They did, however, 
demonstrate significantly less SWS. This result contrasts with previous reviews, which did 
not identify a difference in SWS between BPD and HCs (Oltmanns & Oltmanns, 2015a), or 
suggested a potential increase in SWS in BPD (Simor & Horváth, 2013). Discrepant 
conclusions across reviews are likely partly due to a lack of power in individual studies (i.e., 
null findings, which when combined in meta-analysis reveal significant associations).  
Also in contrast to conclusions from previous reviews (Oltmanns & Oltmanns, 
2015a), we found that patients with BPD experienced significantly shorter REM latency than 
HCs. This finding was robust across several sub-groups, including depression status, sample 
type, and sex. Our finding of increased REM density in BPD is consistent with previous 
reports on BPD (Oltmanns & Oltmanns, 2015a), while reduced REM latency and increased 
REM density have also been robustly associated with depression (Palagini, Baglioni, 
Ciapparelli, Gemignani, & Riemann, 2013). Findings from the sub-group analyses (i.e., 
significant abnormalities in BPD groups with no history of, or current, depression), however, 
support that abnormalities in REM latency and density may not be directly attributable to 
comorbid depression in BPD.  
Comparisons with clinical controls (CCs) 
Meta-analyses of objective sleep studies indicated no overall significant differences between 
BPD groups and CCs across sleep measures. For most of the sleep indices, heterogeneity 
across studies was non-significant precluding sub-analysis. However, where sub-group 
analysis was indicated, it revealed some potential subtle differences between groups. BPD 
patients who had never been depressed and outpatient groups had significantly higher SE 
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than CCs. This could be attributable to the severity of BPD (i.e., outpatients and those 
without a history of depression could have a less severe form of BPD). We also found that 
BPD patients without current comorbid depression and prisoners experienced significantly 
less SWS than CCs. This may be associated with increased alcohol consumption in patients 
with BPD (Lester, Rundell, Cowden, & Williams, 1973) or an overlap between BPD and 
psychotic symptoms (De la Fuente et al., 2004). Our hypotheses remain tentative, however, 
as these findings were not robust across the majority of BPD groups.  
In a previous review comparing the endophenotypes of BPD and Major Depressive 
Disorder (MDD), it was concluded that BPD and depressed patients exhibit differing sleep 
profiles (Goodman et al., 2010). Our quantitative synthesis of all available studies does not 
support this conclusion. Overall, BPD and depressed patients appear to share similar 
disturbances in sleep continuity and architecture, which may suggest potential overlapping 
biological processes in this domain.  
4.1.2. Do individuals with BPD significantly differ from controls on subjective measures of 
sleep? 
Converging evidence demonstrates that inpatients, outpatients, and community populations 
with BPD (or BPD symptoms) report significantly more nightmares than HCs. Again, 
associations appear independent of comorbid depression. Complex associations between 
trauma, nightmares, and BPD are indicated (Claridge et al., 1998; Lereya et al., 2016; Semiz, 
Basoglu, Ebrinc, & Cetin, 2008). Recent prospective evidence suggests that nightmares could 
exacerbate reactions to early trauma increasing risk of subsequent BPD (Lereya et al., 2016). 
These intriguing findings are consistent with contemporary developmental theories for BPD, 
which highlight the potentiation of emotional and behavioural dysregulation across 
development (Crowell, Beauchaine, & Linehan, 2009).  
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4.1.3. Is there a subjective-objective discrepancy in the sleep findings for BPD?  
Consistent with the objective sleep measures, patients with BPD reported significantly poorer 
sleep quality and significantly longer SOL than HCs. In contrast to the objective results, they 
did not differ from HCs on subjective measures of TST and SE. Previously, it was suggested 
that individuals with BPD (common to those suffering from paradoxical insomnia) show 
marked discrepancies between subjective and objective sleep measures (Bastien et al., 2008), 
i.e.,  they report worse sleep quality than HCs while objectively demonstrating similar sleep 
patterns (Bastien et al., 2008; Philipsen et al., 2005). Our findings do not support that 
individuals with BPD are likely to over-estimate their sleep problems. They are, however, 
likely to engage in maladaptive cognitions about their sleep, which could potentially impede 
recovery (Plante et al., 2013a).   
4.1.4. Strengths and Limitations 
Our review has strengths. First, we utilised systematic search procedures to reduce risk of 
bias and ensure comprehensive coverage of the literature. Second, by utilising meta-analysis 
(and thus increasing statistical power) we were able to reveal patterns in the research 
literature that could not be detected through narrative synthesis. This has enabled us to move 
knowledge forward regarding the specific sleep profile of BPD.  
It is also important to highlight the considerable limitations of the available evidence 
and hence the meta-analytical approach we took. First, although interest in sleep and BPD is 
growing (Oltmanns & Oltmanns, 2015a), there were a limited number of studies eligible for 
inclusion in the meta-analysis. Consequently, we had limited power to detect significant 
moderators of effect size in the meta-regression analyses, making it difficult to definitively 
ascertain the independent effects of study factors. This was also apparent in the sub-group 
analyses, where some categories were represented by very few studies. Relatedly, while 
studies were heterogeneous and varied in quality, we could not exclude any based on the 
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quality assessment due to the limited numbers. Our metaregression analysis did not (overall) 
indicate any major effect of study quality on effect size. However, as most studies scored 
poorly in terms of representativeness and response rate, this could impact on the 
generalisability of our results.     
Second, we undertook multiple analyses to explain the observed heterogeneity across 
studies, which could have resulted in type I errors. Nevertheless, we pre-planned and 
grounded our analyses (and research questions) within the extant literature to avoid data 
dredging and reduce the probability of false positives (Thompson & Higgins, 2002). 
Third, some of our findings may have been subject to publication bias. This could 
have resulted in an over estimation of group differences, especially for TST where the funnel 
plot indicated that bias could have played a role.  
Fourth, while it is interesting that many of the objective sleep findings were robust 
independent of comorbid depression, the exclusion of BPD patients with depression will have 
limited the generalisability of the results from these clinical subgroups, as comorbid 
depression is relatively common in BPD (Oltmanns & Oltmanns, 2015a; Zimmerman & 
Mattia, 1999). Nevertheless, significant sleep- BPD associations were also found in 
community (Oltmanns et al., 2014; Selby, 2013) and prison (Harty et al., 2010) studies 
following statistical adjustment for depression symptoms. Further, sub-analyses demonstrated 
that BPD patients both with and without comorbid depression evinced similar sleep 
disturbances. This converging evidence supports the independence of sleep-BPD associations 
across diverse populations.  
Fifth, some studies concentrated on the effects of comorbid or past history of 
depression (Akiskal, Yerevanian, Davis, King, & Lemmi, 1985), or just controlled for 
depression symptoms (Oltmanns et al., 2014), rather than a full range of psychiatric 
disorders. Bipolar disorder and post-traumatic stress disorder, for example, have been 
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associated with both BPD (Zimmerman & Mattia, 1999) and sleep disturbance (Kobayashi, 
Boarts, & Delahanty, 2007; Plante & Winkelman, 2008). Nevertheless, the majority of 
studies did exclude participants with other psychiatric disorders (e.g., psychotic disorder, 
bipolar disorder, substance abuse, PTSD) or controlled for other psychiatric symptoms, e.g., 
substance abuse, PTSD (Harty et al., 2010; Selby et al., 2013), adding support to the 
independence of observed associations between BPD and sleep disturbance.  
Sixth, although most studies included in our meta-analysis incorporated a medication 
wash-out period, in most cases this lasted for a maximum of two weeks. Thus, it is possible 
that medication taken prior to the study may have had a residual impact on the sleep 
disturbances assessed (Battaglia, Ferini-Strambi, Smirne, Bernardeschi, & Bellodi, 1993). In 
a study by Cowdry and Gardner (1988), for example, BPD patients receiving 
benzodiazepines experienced an increase in serious dyscontrol.  
Finally, due to a lack of prospective studies, we were unable to ascertain from the 
extant literature whether sleep problems predate the development of BPD or are a 
consequence of the disorder. There is limited evidence to support that sleep problems may be 
evident before the development of the disorder and contribute to its aetiology (Lereya et al., 
2016; Selby et al., 2013). There is also tentative evidence to suggest that ongoing sleep 
problems can contribute to the chronicity of the disorder (Plante et al., 2013b). It should be 
noted, however, that associations between sleep disturbance and BPD are likely to be bi-
directional, as a number of symptoms and behaviours (e.g., impulsivity, substance abuse, 
chaotic lifestyle) central to BPD are known to disrupt sleep patterns (Fleischer, Schäfer, 
Coogan, Häßler, & Thome, 2012; Winsper & Tang, 2014).   
4.1.5. Clinical and research implications 
Results from this review provide clues regarding the biopsychosocial basis of BPD. It appears 
that BPD may have an independent association with a range of sleep problems (many of them 
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objectively measured) not accounted for by concomitant depression (or other psychiatric 
disorders). This conclusion is supported by converging evidence from clinical studies 
utilising BPD patients with and without comorbid Axis I disorders (e.g., Battaglia et al., 
1993; De La Fuente et al., 2001), and larger studies controlling for the effects of depression 
symptoms and substance dependence on BPD-sleep associations (Harty et al., 2010; 
Oltmanns et al., 2014; Selby, 2013).  
BPD and depressed patients appear to share similar objective sleep disturbances, 
which could indicate an overlap in biological processes. Harty et al. (2010) suggest that sleep 
problems in BPD may represent a more general impairment in self-regulation, and that sleep 
and impaired psychological self-regulation in BPD are underpinned by a common biological 
substrate. It has been proposed that sleep disturbances and emotional dysregulation are 
transdiagnostic processes which are aetiological and maintaining factors for a range of 
psychopathologies (Fairholme et al., 2013). As hypothesised in the “emotional cascades” 
theory of BPD, daytime dysregulation may spill over into the night-time increasing risk of 
sleep disturbance, which in turn may further contribute to dysregulation in a positive 
feedback loop (Selby et al., 2013). Increased amygdala responsiveness to dream stimuli 
(Nielsen & Stenstrom, 2005) leading to hyper-activity of the limbic system (Yoo, Gujar, Hu, 
Jolesz, & Walker, 2007) may represent one potential physiological mechanism contributing 
to this cycle.  
More prospective cohort studies from childhood onwards are now needed to ascertain 
whether sleep problems are a marker, cause, or consequence of BPD, and to elucidate the 
aetiological pathways involving sleep, dysregulation and BPD. Studies incorporating a range 
of psychopathological outcomes (e.g., BPD, depression, psychosis, bipolar disorder, anxiety) 
simultaneously may help shed further light on the specific nature of sleep problems in BPD 
across development (Harvey, 2015). Such studies should be complemented by experimental 
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and micro-longitudinal (McCall et al., 2010) designs  to investigate the proximal impact of 
sleep disruptions on BPD symptoms at the biological  (Yoo et al., 2007) and phenotypical 
(Anderson & Platten, 2011) level. It should be highlighted that the BPD diagnosis (in the 
categorical form used in many of the included studies) comprises a heterogeneous group of 
individuals. Indeed, the requirement for five out of nine symptoms means that there are 
numerous ways to meet the BPD diagnosis (Linehan, Cochran, & Kehrer, 2001). Hafizi 
(2013) suggests that specific types of sleep problem may be associated with specific BPD 
symptoms (e.g., nightmare disorder with self-harm and suicide, short sleep length with 
affective instability). Thus, to further our understanding of sleep disturbance in this complex 
disorder, future studies may examine associations between specific sleep problems and 
individual symptoms (or symptom clusters) of BPD.  
Sleep problems may not only worsen symptom course in BPD (Selby et al., 2013) but 
also heighten risk of suicide (Balestrieri et al., 2006; Winsper & Tang, 2014) and self-harm 
(Semiz et al., 2008) in this vulnerable population. Hence, mental health professionals should 
routinely assess the degree to which patients with BPD are experiencing sleep difficulties. 
Sedative-hypnotic regimens should be approached with caution (National Institute for 
Clinical Excellence, 2009), as patients with BPD may be likely to use medications in excess, 
thus exacerbating suicide risk (Plante et al., 2013a; Winsper & Tang, 2014).  
This review highlights several potential treatment approaches for sleep problems in 
BPD. Cognitive Behaviour Therapy for insomnia (CBT-I) is an effective treatment (Harvey, 
2015), which may help reduce maladaptive sleep related cognitions and potentially aid 
recovery in BPD (Plante et al., 2013a). Considering the high incidence and potential 
aetiological role of nightmares in BPD (Selby et al., 2013), imagery rescripting and rehearsal 
(IRR) and imaginal confrontation with nightmare contents (ICNC) may be other evidence-
based approaches for some patients (Hansen, Höfling, Kröner-Borowik, Stangier, & Steil, 
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2013). Timed light exposure, planned, regular sleep schedules, and interpersonal and social 
rhythms therapy (Harvey, 2015) are further options for disturbed circadian rhythms in BPD 
(Bromundt et al., 2013; Dagan et al., 1998; Huỳnh et al., 2015).  
In view of the centrality of dysregulation to BPD and sleep disturbance (Marwaha, 
Balbuena, Winsper, & Bowen, 2015), an integrated treatment approach focusing on 
promoting sleep hygiene (Huỳnh et al., 2015; NICE, 2009) and reducing daytime rumination 
(Selby et al., 2013) and emotional dysregulation (Blum et al., 2008) is warranted.  
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Table 1. List of acronyms and full name used throughout the review 
Acronyms Full name  
BPD Borderline Personality Disorder 
CBT-I Cognitive Behaviour Therapy for Insomnia 
CC/s Clinical Control/s 
CDSR Cochrane Database of Systematic Reviews 
CRD Centre for Reviews and Dissemination 
DSPS Delayed Sleep Phase Syndrome 
EEG Electroencephalogram 
HC/s Healthy Control/s 
ICNC Imaginal Confrontation with Nightmare Contents 
IRR Imagery Rescripting and Rehearsal 
MOOSE Meta-analysis of Observational Studies in Epidemiology 
NWAKE Number of Awakenings 
NOS Newcastle Ottawa Scale 
PRISMA Preferred Reporting Items for Systematic Review and Meta-analysis 
PTSD Post-Traumatic Stress Disorder  
PSG Polysomnography 
QA Quality Assessment 
REM Rapid Eye Movement 
SE Sleep Efficiency 
SMD Standardised Mean Difference 
SOL Sleep Onset Latency 
SWS Slow Wave Sleep 
TST Total Sleep Time 
WASO Wake After Sleep Onset 
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Table 2. Details and Main Results of Studies Reporting on the Sleep Characteristics of Individuals with BPD diagnosis or symptoms 
Author/ 
Synthesis 
(Design) 
Year/ 
Country 
% 
female 
Sample 
(N, controls) 
Sample  
frame 
Age (SD) 
In years 
Sleep 
assessment 
/medication 
Co-morbidity 
 
BPD assessment 
tool 
Main results 
(Akiskal et al.) 
MA 
 
1985 
USA 
50% 
43% 
43% 
38% 
24 BPD 
30 depression 
14 HCs 
16 other PDs 
Outpatients 
(Sleep 
disorders 
centre) 
36 (11) 
46 (12) 
36 (16) 
45 (13) 
Polysomnography/ 
No psychoactive 
drugs for 2 weeks 
Excluded: Definite or 
probable depressive episodes 
during the preceding year; 
narcolepsy and sleep apnea 
DSM-III criteria 
for BPD 
 
BPD patients had significantly shorter REM latency than healthy and PD 
controls. They did not significantly differ in REM latency from depressed 
controls. 
  
(Asaad, Okasha, 
& Okasha)  
 MA 
 
2002 
Egypt 
60% 
60% 
60% 
20 BPD  
20 depression 
20 healthy 
controls 
Outpatients 27.04 (7.53) 
27.83 (7.65) 
27.8 (4.62) 
Polysomnography; 
Questionnaire/ 
No psychotropic 
drugs for 2 weeks 
Excluded: Past or current 
affective disorder or other 
psychiatric disorder; sleep 
apnea 
ICD-10 
“emotionally 
unstable PD 
BPD patients significantly differed from HCs on SOL (longer), SE 
(lower), SWS (less), REM % (greater), REM latency (shorter) & REM 
density (higher). BPD patients significantly differed from depressed 
controls on SOL (shorter), SE (higher), NWAKE (less), REM latency 
(longer), REM density (lower). 
 
(Bastien et al.) 
MA 
 
2008 
Canada 
100% 
67% 
73% 
12 BPD 
15 good sleepers  
15 psycho* 
insomnia 
15 para*  
insomnia  
Outpatients 33.3 (10.7) 
34.1 (9.9) 
36.6 (7,1) 
Polysomnography; 
Sleep diary; ISI/  
No psychotropic 
drugs or sleep 
promoting 
medication 
Excluded: Axis I psychiatric 
disorder or alcohol/drug 
abuse during past year; other 
sleep disorder, e.g., apnea   
DSM-IV criteria 
for BPD 
DIB-R (≥7) 
BPD patients had significantly longer SOL, less TST, and lower SE than 
good sleepers (GS). BPD patients had more stage 4 sleep than controls 
with insomnia. Subjective reports of sleep difficulties did not differ 
between patients with BPD and GS. Controls with insomnia had 
significantly poorer subjective sleep than BPD patients and GS. 
(Battaglia et al.) 
MA 
 
1993 
Italy 
60% 
60% 
10 BPD 
10 healthy 
controls 
Inpatients 25.4 (4.5) 
24.8 (3.5) 
Polysomnography/ 
2 weeks without 
medication 
Excluded: Past or current 
depression, bipolar disorder, 
cyclothymia, dysthymia, 
schizophrenia 
DSM-III criteria 
for BPD 
BPD patients had significantly longer SOL, more WASO and number of 
awakenings, lower SE, and shorter REM latency than HCs.  
(Bell, Lycaki, 
Jones, Kelwala, & 
Sitaram) MA 
1983 
USA 
67% 
56% 
8 primary BPD 
11 primary 
depression 
Inpatients 29.7 (3.9) 
36.5 (13.2) 
Polysomnography/ 
2 weeks without 
medication 
All had co-morbid depression DSM-III criteria 
for BPD 
 
There were no significant differences in SOL, SE, REM % or latency, 
TST or WASO between BPD and depressed only groups. 
(Benson et al.) 
MA 
1990 
USA 
0% 
0% 
 
10 BPD 
(veterans) 
15 HCs 
Inpatients 32.7 (7.6) 
30.5 (7.6) 
 
Polysomnography/ 
2 weeks medication 
free 
No history of, or co-morbid, 
major depressive disorder 
DSM-III criteria 
for BPD 
 
BPD patients had significantly less TST, more stage 1 sleep and less stage 
4 sleep than HCs. The groups did not differ in REM latency.  
(Bromundt et al.) 
N 
2012 
Switzerland 
100% 
 
14 BPD 
10 healthy 
controls 
 
Outpatients 30.1 (6.0) 
25.7 (4.8) 
 
Wrist actimetry; 
PSQI; MEQ; 
SPAQ/ 10/14 BPD 
patients on stable 
medication 
Not reported (though BPD 
group had significantly 
higher depression and anxiety 
symptoms); no sleep apnea 
DSM-IV criteria 
for BPD 
BPI (>8) 
BPD patients exhibited a wider range in Relative Amplitude (RA) than 
HCs (p=0.019). BPD patients with high RA had regular sleep-wake 
cycles, while those with low RA group had irregular rhythms and more 
BPD symptoms. Morning LT significantly improved daytime alertness (F 
[1, 12] = 9.33, p = 0.010), and attenuated atypical depression scores (t [13] 
= 2.55, p = 0.024) in patients with BPD.  
 
(Claridge et al.) 
N 
 
 
 
 
 
 
1998 
Canada 
100% 60 women 
(study1) 
66 women 
(study2) 
203 women 
(study3) 
Student 
population 
20.4  
(range=18-30 
years) 
21.2 
Nightmare Distress 
Scale (13 item self-
report); Dream and 
Nightmare Enquiry/ 
not reported 
Not reported STB 
 
Study 1: BPD symptoms were significantly correlated with ND (r=0.42, 
p< 0.001) and remained a significant predictor of nightmares following 
control for sexual abuse and neglect. 
Study 2: BPD symptoms were significantly correlated with adult (r =0.31, 
p< 0.01), but not childhood (r =0.07) nightmare content. 
Study 3: ND was significantly positively correlated with BPD symptoms 
(r=0.49, p< 0.001) following control for abuse and neglect. 
 
(Dagan et al.) N 
 
 
 
1998 
Israel 
48% 52 adolescents 
mixed diagnoses 
11 BPD 
Inpatients 17.4 (2) Sleep wake habits 
Interview/ all on 
medication 
 
4 of the 5 BPD patients with 
DSPS had no co-morbidities  
MCMI 
PDQ-R 
50% of adolescent patients with Delayed Sleep Phase Syndrome had BPD 
(Odds Ratio=7.67; 95% CI=1.70, 34.48). 
Synthesis: MA=meta-analysis; N=narrative; HC=Healthy control; *psycho= psychophysiological; *para= paradoxical; DIB-R=Revised Diagnostic Interview for Borderlines; STB=Borderline Personality Scale; MCMI=Millon Clinical Multiaxial Inventory; PDQ-
R=Personality Diagnostic Questionnaire Revised 
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(De la Fuente, 
Bobes, Vizuete, & 
Mendlewicz) 
MA 
2001 
France 
70% 
75% 
70% 
20 BPD  
20 depression 
20 HCs 
Inpatients 32.4 (6.9) 
38.5 (7.6) 
35.5 (5.8) 
 
Polysomnography/ 
10 days medication 
free 
 
Excluded: Other Axis I 
disorders 
DSM-III criteria 
for 
BPD 
DIB-R (≥7) 
BPD patients had significantly less TST, longer SOL, and a greater % of 
wakefulness than HCs. BPD patients had a longer duration of REM sleep, 
less stage 3, stage 4 and SWS than both control groups.  
BPD patients had more stage 2 sleep than depressed controls. 
(De la Fuente et 
al.)* N 
 
 
2004 
France 
70% 
70% 
75% 
75% 
20 BPD  
20 RBD 
20 MD 
20 HCs 
Inpatients 32.4 (6.9) 
36.6 (7.6) 
35.9 (3.4) 
35.5 (5.8) 
Polysomnography/ 
10 days medication 
free 
 
Excluded: Other Axis I 
disorders 
DSM-III criteria 
for 
BPD 
DIB-R (≥7) 
Patients with BPD experienced significantly less stage 3 sleep and SWS, 
and significantly longer REM duration than patients with RBD. They did 
not significantly differ on SOL; TST; stage 1 or 2 sleep; or REM latency.  
(Harty et al.) N 
 
 
 
2010 
USA 
30% 
 
513 jail inmates 
 
Prisoners 32 (10) 
 
5 item index self-
report index/ 
not reported 
Not reported (though analysis 
controlled for depression 
symptoms and substance 
dependence) 
PAI-BOR scale 
 
BPD symptoms were significantly correlated with self-reported sleep 
problems (r=.43). This significant correlation held following control for 
cognitive, affective and physiological depression (r=.20), and substance 
dependence (r=.39). 
(Hornung et al.) 
 MA 
 
 
2008 
Germany 
100% 
100% 
15 BPD 
15 HCs 
Inpatients 26.1 (6.1) 
25.6 (6.8) 
 
Portable recording 
device; sleep 
questionnaire/ no 
medication 3 days  
3 of the BPD patients had co-
morbid depression 
DSM-IV criteria 
for BPD 
BPD patients reported significantly poorer sleep quality and less 
restorative value of sleep in comparison to HCs. They did not significantly 
differ in objective measures of SOL, TST, WaSO, sleep stage or REM 
latency. 
(Huỳnh et al.) 
 MA/N 
 
 
 
 
2015 
Canada 
83% 
67% 
65% 
18 BPD 
6 BD 
20 HCs 
Outpatients 16 (1.1) 
16.7 (1.0) 
14.7 (1.0) 
Actigraph/ most 
patients on 
psychotropic 
medication 
 
Excluded: Euthymic (i.e., 
current depression 
symptoms), mania, psychotic 
features, bipolar 
DSM-IV criteria 
for BPD 
DIB-R (≥8) 
 
On school/work days, adolescents with BPD spent a significantly lower % 
of time asleep than bipolar controls (p=0.04). Time awake in bed did not 
significantly differ between BPD & HCs. On schedule-free days, youths 
with BPD and bipolar disorder spent more time in bed than HCs (ns). 
Adolescents with BPD demonstrated more inter-daily total sleep time 
variability than bipolar and HC groups. 
(Lahmeyer et al.) 
 MA 
 
1987 
USA 
53% 
50% 
 
21 BPD 
20 depression 
 
Outpatients 29.0 (3.4) 
35.2 (4.8) 
 
Polysomnography/ 
14 days without 
medication 
Excluded: Major affective 
disorders and schizophrenia 
DSM-III criteria 
DIB (≥7) 
 
BPD patients had significantly less stage 1 sleep than depressed controls 
and significantly greater SE. The 2 groups did not differ on TST, SOL or 
REM (&, density and latency) indices. 
(Lereya et al.) 
N 
 
 
 
 
2016 
UK 
51.4% 6,050 Community 
population of 
young 
adolescents 
11.8 Mother reported/ 
not reported 
Not reported, but controlled 
for emotional and 
behavioural dysregulation 
within the analysis 
UK-CI-BPD 
 
Chronic nightmares significantly predicted BPD (OR=1.67; 95% CI=1.18, 
2.38). This association was mediated by daytime emotional and 
behavioural dysregulation (β =0.016, p<0.001). Associations between 
early emotional temperament (β=0.001, p=0.018); abuse (β=0.015, 
p=0.018); maladaptive parenting (β=0.002, p=0.021), and subsequent 
BPD were all mediated by nightmares. 
(Lindberg et al.) 
MA 
 
 
2003 
Finland 
0% 
0% 
0% 
10 ASPD  
6 ASPD with 
BPD 
11 HCs 
Prisoners 
(charged with 
violent crimes) 
28.1 (3.40) 
34.8 (4.45) 
32.5 (3.44) 
 
Polysomnography/ 
2 weeks medication 
free 
 
Excluded: Axis I disorder 
(other than drug/alcohol 
abuse), other personality 
disorders 
DSM-IV criteria 
for BPD 
 
Groups did not differ on TST, SOL, SWS, stage 1 sleep or REM 
measures. The BPD group had significantly more awakenings and 
significantly lower SE than ASPD and HCs. BPD and ASPD groups had 
significantly more stage 4 sleep than HCs. 
 
(Lloyd et al.) N 
 
1983 
USA 
66% 27 BPD; 178 
mixed disorders 
Outpatients 20-59 years 
 
MMPI-168/  
not reported 
Not reported DSM-III criteria Outpatients with BPD were significantly more likely to report nightmares 
every few nights than controls (p< .01).  
(Mahmood, 
Tripodi, Vaughn, 
Bender, & 
Schwartz) N 
 
2012 
USA 
100% 475 BPD 
330 controls 
Prisoners 33.5 (8.5) One item: ”have 
trouble sleeping in 
prison”/  
not reported 
Not reported though BPD 
was correlated with anxiety 
and depression 
SCID-II 
 
Female prisoners with BPD were more likely to experience self-reported 
sleep problems following control for demographic variables; though the 
difference did not quite reach statistical significance: OR=1.33; 95% CI = 
0.90, 1.94. 
 
(McNamara et al.) 
MA 
 
1984 
USA 
100% 
70% 
100% 
10 BPD 
10 depression 
10 HCs 
Inpatients (2 
outpatients) 
28.1 (3.8) 
27.4 (5.1) 
27.8 (4.5) 
Polysomnography/ 
2 weeks medication 
free 
BPD patients had variety of 
Axis I co-morbidities (6 had 
major depression) 
DIB (≥7) 
 
The BPD group significantly differed from HCs on TST (less), SE (less), 
and REM latency (shorter) and REM density (greater).    
(Oltmanns et al.) 
N 
 
 
2014 
USA 
57% 633 older adults 
 
Community 
sample 
62.3 (2.8) 
 
ISI (self-report 
questionnaire)/ 
not reported 
Not reported, but controlled 
for depression within the 
analysis 
SIDP-IV 
MAPP 
 
BPD pathology was significantly predictive of insomnia symptoms 
following control for major depression, body mass index, race, gender, 
and other personality disorders: β=0.23, p<0.001.   
 
*Overlapping sample with De La Fuente 2001; RBD=Recurrent Brief Depression; PAI-BOR=Personality Assessment Inventory;*Sample from McNamara (1984); MMPI-168=Minnesota Multiphasic Personality Inventory; ISI=Insomnia Severity Index; SF-
A=Schlaffragebogen A; DBAS-1 Dysfunctional Beliefs About Sleep; UK-CI-BPD=UK Childhood Interview for DSM-IV BPD; SCID-II=Structured Clinical Interview for DSM-IV; SIDP-IV=Structured Interview for DSM–IV PDs; MAPP=Multi-Source Assessment 
of Personality Pathology 
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(Philipsen et al.) 
MA 
 
 
2005 
Germany 
100% 
100% 
20 BPD 
20 HCs 
Outpatients 28.6 (6.9) 
28.6 (7.1) 
Polysomnography; 
SF-A, PSQI/ 
2 weeks medication 
free 
Excluded: Any other 
psychiatric disorder within 
six months of the sleep 
assessment; sleep apnea 
DSM-IV criteria 
for BPD, SCID-II 
 
BPD patients experienced significantly less stage 2-sleep than HCs. They 
did not differ on other objective sleep measures (SOL; TST; SE; SWS; 
REM). Self-reported sleep quality was significantly worse in BPD 
patients. 
(Plante et al.) N 
 
 
 
2013a 
 
83% 
80% 
 
105 recovered 
BPD; 118 non-
recovered BPD 
Outpatients 41.2 (5.4) 
44.2 (6.0) 
 
DBAS-16/ 
Some using sleep 
medications 
 
Non-recovered group had 
range of co-morbidities 
including major depression, 
panic disorder and PTSD 
SCID-I 
DIB-R 
DIPD-R 
 
Following adjustment for age, sex, depression, anxiety and primary sleep 
disorders, non-recovered BPD patients reported significantly more 
maladaptive sleep-related cognitions than the recovered group: p=0.0009. 
(Plante et al.) MA 
 
 
 
2013b 
 
83% 
80% 
 
105 recovered 
BPD; 118 non-
recovered BPD 
Outpatients 41.2 (5.4) 
44.2 (6.0) 
 
PSQI/ 
Some using sleep 
medications 
 
Non-recovered group had 
range of co-morbidities 
including major depression, 
panic disorder and PTSD 
SCID-I 
DIB-R 
DIPD-R 
 
Non-recovered BPD patients had significantly worse sleep quality, longer 
SOL, increased odds of using sleep medication, and more daytime 
dysfunction than recovered BPD patients. 
(Reynolds et al.) 
MA 
 
 
 
 
1985 
USA 
100% 
70% 
70% 
100% 
10 BPD 
(retrospective)*  
10 BPD 
(prospective) 
10 depression 
10 HCs 
Inpatients 28.1 (3.8) 
25.4 (6.4) 
27.4 (5.1) 
27.8 (4.5) 
Polysomnography/ 
2 weeks medication 
free 
 
All BPD had co-morbid 
affective disorder 
DIB (≥7) 
 
The BPD group (prospective) had significantly less TST, significantly 
longer SOL and significantly lower SE than HCs. They did not 
significantly differ from depressed patients on sleep assessments. 
(Sansone et al.) N 
 
 
2010 
USA 
74.6% 
 
76 outpatients 
 
Outpatients 41.6 (13.8) 
 
PSQI/ 
 
 
Excluded: Psychotic illness PDQ-4 
SHI 
Poor sleep quality was significantly associated with BPD symptoms (p< 
0.05) 
(Schredl et al.) 
MA 
 
 
 
2012 
Germany 
100% 
100% 
27 BPD (18 no 
PTSD) 
20 HCs 
Outpatients 29.3 (7.7) 
24.3 (3.8) 
 
Polysomnography; 
SF-B, LISST/no 
medication for 3 
months 
 
Excluded: Lifetime 
schizophrenia or bipolar I 
disorder, current drug/alcohol 
abuse or major depression   
IPDE 
 
BPD patients experienced significantly more awakenings and time awake, 
shorter REM latency, and greater REM density than HCs. BPD patients 
reported much lower sleep quality and feelings of being refreshed than 
HCs. BPD patients also reported significantly more parasomnias and 
nightmares than HCs. 
(Selby et al.) 
MA/N 
 
 
 
 
2013a 
USA 
66% 
 
16 BPD patients 
31“dysregulated” 
controls 
Community 
and 
undergraduate 
Not reported 
 
Questionnaire/ 
Some participants 
taking psychotropic 
medication 
Not reported though 
associations controlled for 
MDD diagnosis 
SCID-II 
 
BPD patients experienced more frequent nightmares. BPD diagnosis 
interacted with baseline trait rumination to prospectively predict number 
of nightmares. Daytime emotional dysregulation prospectively predicted 
nightmares. These associations remained following adjustment for sleep 
quality, depression and Post-Traumatic Stress Disorder.   
(Selby)  
N 
 
 
2013 
USA 
Not 
reported 
5,692 adults Community Not reported Questionnaires/ 
not reported 
 
Not reported though 
associations adjusted for Axis 
I disorders 
IPDE  
 
BPD was significantly associated with chronic sleep disturbances (i.e., 
difficulty initiating sleep, difficulty maintaining sleep, and waking earlier 
than desired). BPD symptoms interacted with sleep problems to predict 
social, emotional, cognitive, and self-care impairment.    
(Semiz et al.) 
MA 
 
 
 
2008 
Turkey 
45% 
43% 
88 BPD  
100 HCs 
Inpatients 21.7 (3.6) 
22.3 (3.9) 
VDAS; PSQI/ 
No medication for 
4 weeks  
Excluded: Psychotic or mood 
disorder or PTSD in the past 
year 
SCID BPD patients experienced significantly more nightmares and dream 
anxiety, and significantly poorer sleep quality and daytime functioning 
than controls. BPD patients with nightmare disorder experienced greater 
psychopathology (i.e., self-harm, substance abuse, dissociation) than those 
without nightmare disorder.   
(Simor et al.) 
MA 
 
2010 
Hungary 
83% 
83% 
23 BPD  
23 HCs 
Outpatients NR VDAS; DQQ/ 
6/23 BPD patients 
on antidepressants 
Excluded: Other Axis II 
disorder or PTSD 
SCID-II 
 
BPD patients experienced significantly more dream disturbances, in terms 
of nightmares; bad dreams; night-terror symptoms, and dream anxiety. 
Dream disturbances were positively correlated with neuroticism.   
(Taherifard et al.) 
MA 
 
2015 
Iran 
0% 
 
50 BPD 
50 ASPD 
50 HCs 
Outpatients 28.5 (4.33) 
29.72 (5.07) 
25.88 (3.97) 
PSQI/not reported 
 
Not reported IDI for BPD 
 
BPD patients had significantly lower sleep quality than controls.  
*Sample from the McNamara (1984) study thus results on prospective sample used 
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Table 3. Meta-analysis results comparing the objective sleep characteristics of BPD patients to healthy and clinical controls 
Sleep characteristic Versus healthy controls Versus clinical controls 
  
Pooled 
SMD 
 
 
Lower CI 
 
 
Higher CI 
 
 
Hetero-
geneity 
P value for 
group 
difference 
 
Publication 
biasb 
 
Pooled SMD 
 
 
Lower CI 
 
 
Higher CI 
 
 
Hetero-
geneity 
P value for 
group 
difference 
 
Publication 
biasb 
Sleep onset latency 
(Sensitivity analysisa) 
0.626 
(0.653) 
0.229 
(0.214) 
1.023 
(1.091) 
67.2%* 
(69.8%) 
0.002 
(0.004) 
No -0.072 
(-0.107) 
-0.420 
(-0.480) 
0.277 
(0.266) 
40.6% 
(44.7%) 
0.687 
(0.574) 
No 
Total sleep time -0.556 
(-0.674) 
-1.090 
(-1.227) 
-0.022 
(-0.122) 
74.0%* 
(71.2%) 
0.041 
(0.017) 
Yes 0.279 
(0.326) 
-0.104 
(-0.091) 
0.662 
(0.742) 
44.1% 
(48.8%) 
0.153 
(0.125) 
No 
Wake after sleep onset 0.653 
(N/A) 
0.073 
(N/A) 
1.233 
(N/A) 
54.0% 
(N/A) 
0.027 
(N/A) 
Some 
indication 
-0.389 
(N/A) 
-1.005 
(N/A) 
0.226 
(N/A) 
46.3% 
(N/A) 
0.215 
(N/A) 
No 
Number of awakenings 0.874 
(N/A) 
0.132 
(N/A) 
1.616 
(N/A) 
80.5%* 
(N/A) 
0.021 
(N/A) 
No 0.762 
(N/A) 
-1.361 
(N/A) 
2.885 
(N/A) 
93.2%* 
(N/A) 
0.482 
(N/A) 
No  
Sleep efficiency -1.015 
(-1.169) 
-1.555 
(-1.660) 
-0.476 
(-0.678) 
74.0%* 
(62.5%) 
<0.001 
(<0.001) 
Slight 
indication 
0.179 
(0.250) 
-0.623 
(-0.627) 
0.981 
(1.127) 
84.5%* 
(85.7%) 
0.662 
(0.576) 
Slight 
indication 
REM latency -0.812 
(N/A) 
-1.154 
(N/A) 
-0.470 
(N/A) 
55.0%* 
(N/A) 
<0.001 
(N/A) 
Some 
indication 
0.039 
(N/A) 
-0.409 
(N/A) 
0.488 
(N/A) 
69.3%* 
(N/A) 
0.864 
(N/A) 
No 
REM % 0.219 
(N/A) 
-0.122 
(N/A) 
0.560 
(N/A) 
46.3% 
(N/A) 
0.207 
(N/A) 
No 0.078 
(N/A) 
-0.269 
(N/A) 
0.426 
(N/A) 
36% 
(N/A) 
0.659 
(N/A) 
No 
REM density 0.741 
(N/A) 
0.263 
(N/A) 
1.218 
(N/A) 
56.3%* 
(N/A) 
0.002 
(N/A) 
No -0.206 
(N/A) 
-1.540 
(N/A) 
1.129 
(N/A) 
90.8* 
(N/A) 
0.763 
(N/A) 
No 
Stage 1 sleep 0.297 
(N/A) 
-0.010 
(N/A) 
0.604 
(N/A) 
38.0% 
(N/A) 
0.058 
(N/A) 
No -0.303 
(N/A) 
-0.655 
(N/A) 
0.050 
(N/A) 
37.9% 
(N/A) 
0.092 
(N/A) 
No 
Stage 2 sleep -0.181 
(N/A)  
-0.569 
(N/A) 
0.208 
(N/A) 
60.7%* 
(N/A) 
0.361 
(N/A) 
No 0.299 
(N/A) 
-0.095 
(N/A) 
0.693 
(N/A) 
49.5% 
(N/A) 
0.137 
(N/A) 
Slight 
indication 
Slow wave sleep -0.529 
(N/A) 
-0.904 
(N/A) 
-0.154 
(N/A) 
47.8% 
(N/A) 
0.006 
(N/A) 
No -0.418 
(N/A) 
-1.189 
(N/A) 
0.353 
(N/A) 
77.4%* 
(N/A) 
0.288 
(N/A) 
No 
* Significant heterogeneity across studies; a Sensitivity analysis excluding studies with patients on psychotropic medication at the time of testing; b publication bias estimated with funnel plots; NA= All studies 
excluded patients on psychotropic medication; SMD=Standardised Mean Difference; CI=Confidence Interval 
 
 
 
 
 
 29 
 
Table 4. Sub-group analysis results comparing the objective sleep characteristics of BPD patients to healthy and clinical controls 
Subgroup Sleep characteristic (SMD and 95% Confidence Intervals reported) 
Depression status TST SOL NWAKE SE REM latency REM density Stage 2 sleep 
   No past (or current) depression -1.31 
(-2.19, -0.42) 
1.63      
(0.56, 2.69) 
0.28  
(- 0.36, 0.92) 
-1.59 
(-2.18, -1.00) 
-1.44     
(-2.44, -0.44)   
0.74 
(0.04, 1.44) 
0.39 
(-0.58, 1.36) 
   No current depression -0.14 
(-0.67, 0.38) 
0.24 
(-0.09, 0.57) 
1.28  
(0.14, 2.41) 
-0.66     
(-1.38, 0.06) 
-0.58 
(-0.89, - 0.26) 
0.48 
(-0.69, 1.66) 
-0.47  
(-0.92, -0.03) 
   Co-morbid depression -1.68 
(-2.41, -0.94) 
1.11 
(0.44, 1.78) 
N/A -1.32 
(-2.01, -0.63) 
-0.77 
(-1.41, -0.12) 
1.35 
(0.37, 2.33) 
-0.17 
(-0.80, 0.45) 
Sample type        
   Inpatients -0.99 
(-1.79, -0.20) 
0.78 
(0.33, 1.23) 
0.70 
 (-0.21,1.60) 
-1.48 
(-2.06, -0.90) 
-0.64 
(-1.10, -0.19) 
0.81 
(-0.20, 1.82) 
0.23  
(-0.29, 0.75) 
   Outpatients -0.22     
(-0.76, 0.32) 
0.59     
(-0.19, 1.36) 
0.46  
(- 0.09, 1.01) 
-0.54 
(-1.09, 0.01) 
-0.89  
(-1.45, -0.32) 
0.67 
(-0.12, 1,45) 
-0.47 
(-0.89, -0.05) 
   Prison populations 0.52     
(-0.50, 1.53) 
-0.09     
(-1.09, 0.91) 
4.63 
(2.70, 6.57) 
-3.12 
(-4.62, -1.63) 
-1.47  
(-2.59, -0.34) 
 
N/A 
-1.17 
(-2.27, -0.07) 
Sleep assessment        
   Polysomnography -0.85 
(-1.36, -0.34) 
0.73 
(0.22, 1.24) 
N/A -1.17 
(-1.66, -0.68) 
-0.87 
 (-1.22, -0.52) 
N\A N\A 
   Portable device 0.41 
(-0.13, 0.95) 
0.19  
(- 0.35, 0.73) 
N/A 0.30  
(-0.39, 0.99) 
-0.09 
(-0.96, 0.77) 
N\A N/A 
Sex        
   Mixed  -0.96 
(-1.91, -0.01) 
1.09 
(0.58, 1.59) 
0.28  
(-0.36, 0.92) 
-1.10 
(-1.93, -0.26) 
-1.21 
(-1.87, -0.56) 
0.74 
(0.04, 1.44) 
-0.13 
(-0.61, 0.36) 
   Female -0.17 
(-0.83, 0.50) 
0.08  
(-0.33, 0.49) 
0.62 
(-0.05, 1.29) 
-0.53 
(-0.92, -0.14) 
-0.45 
(-0.78, -0.12) 
0.74 
(-0.19, 1.66) 
-0.35 
(-0.87, 0.17) 
   Male -0.41 
(-2.20, 1.38) 
-0.09 
(-1.09, 0.91) 
4.63 
(2.70, 6.57) 
-3.12 
(-4.62, -1.63) 
-0.90 
(-1.84, 0.05) 
N/A -0.05 
(-2.18, 2.09) 
Significant group difference in bold face; negative figures represent that the BPD group experienced less TST, SE, and REM latency than HCs, positive figures indicate that the BPD group experienced more SOL & REM density  
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Table 5. Meta-analysis results comparing the self-reported sleep characteristics of BPD patients to controls 
 Pooled SMD 
 
Lower CI 
 
Higher CI 
 
Hetero-geneity P value for group 
difference 
Publication biasb 
Nightmares 
(sensitivity analysis a) 
1.07 
(1.32) 
0.43 
(0.73) 
1.71 
(1.91) 
81.8* 
62.5 
0.001 
<0.001 
No 
Sleep quality 1.99 
(2.28) 
0.96 
(1.24) 
3.03 
(3.32) 
95.8* 
(89.0*) 
<0.001 
(<0.001) 
No 
Sleep onset latency 0.35 
(0.32) 
0.10 
(-0.19) 
0.60 
(0.84) 
7.9 
(36.1) 
0.006 
(0.209) 
No 
Total sleep time -0.35 
(-0.60) 
-0.76 
(-1.23) 
0.06 
(0.03) 
61.7%* 
56.5 
0.095 
0.062 
Yes 
Sleep efficiency -0.76 
(-1.18) 
-1.65 
(-1.79) 
0.12 
(-0.58) 
85.8* 
(23.4) 
0.09 
(<0.001) 
Yes 
* Significant heterogeneity across studies; Significant group difference in bold face; a Sensitivity analysis excluding studies with patients on psychotropic medication at the 
time of testing; b publication bias estimated with funnel plots; SMD=Standardised Mean Difference; CI=Confidence Interval 
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